Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

Fresenius Medical Care Tells Reuters In Statement That Novo Nordisk's Ozempic And Other GLP-1 Drugs May Slow The Progression Of Chronic Kidney Disease, But Overall Mortality Of Treated Individuals Would Also Be Reduced

Author: Benzinga Newsdesk | October 12, 2023 12:00pm

- Reuters

Posted In: DVA FMS NVO